scholarly journals Glycomic and Proteomic Profiling of Pancreatic Cyst Fluids Identifies Hyperfucosylated Lactosamines on theN-linked Glycans of Overexpressed Glycoproteins

2012 ◽  
Vol 11 (7) ◽  
pp. M111.015792 ◽  
Author(s):  
Benjamin F. Mann ◽  
John A. Goetz ◽  
Michael G. House ◽  
C. Max Schmidt ◽  
Milos V. Novotny
2018 ◽  
Vol 2018 ◽  
pp. 1-12 ◽  
Author(s):  
Agnieszka Paziewska ◽  
Marcin Polkowski ◽  
Tymon Rubel ◽  
Jakub Karczmarski ◽  
Anna Wiechowska-Kozlowska ◽  
...  

Pancreatic cyst fluids (PCFs) enriched in tumour-derived proteins are considered a potential source of new biomarkers. This study aimed to determine compositional and quantitative differences between the degradome and proteome of PCFs aspirated from different types of pancreatic cyst lesions (PCLs). 91 patients who underwent endoscopic ultrasound-fine needle aspiration under routine clinical diagnosis of PCLs were enrolled. Four cysts were malignant (CAs), and 87 were nonmalignant and consisted of 18 intraductal papillary mucinous neoplasms (IPMNs), 14 mucinous cystic neoplasms (MCNs), nine serous cystic neoplasms (SCNs), 29 pseudocysts (PCs), and 17 unclassified. Profiles of the <5 kDa fraction, the degradome, and the trypsin-digested proteome were analysed using an LTQ-Orbitrap Elite mass spectrometer coupled with a nanoACQUITY LC system. Qualitative analyses identified 796 and 366 proteins in degradome and proteome, respectively, and 689 (77%) and 285 (78%) of them were present in the Plasma Proteome Database. Gene Ontology analysis showed a significant overrepresentation of peptidases and peptidases inhibitors in both datasets. In the degradome fraction, quantitative values were obtained for 6996 peptides originating from 657 proteins. Of these, 2287 peptides were unique to a single type, and 515 peptides, derived from 126 proteins, were shared across cyst types. 32 peptides originating from 12 proteins had differential (adjustedp-value ≤0.05, FC ≥1.5) abundance in at least one of the five cysts types. In proteome, relative expression was measured for 330 proteins. Of them, 33 proteins had significantly (adjustedp-value ≤0.05, FC ≥1.5) altered abundance in at least one of the studied groups and 19 proteins appeared to be unique to a given cyst type. PCFs are dominated by blood proteins and proteolytic enzymes. Although differences in PCF peptide composition and abundance could aid classification of PCLs, the unpredictable inherent PCF proteolytic activity may limit the practical applications of PCF protein profiling.


Oncotarget ◽  
2019 ◽  
Vol 10 (40) ◽  
pp. 4026-4037
Author(s):  
Ali Sakhdari ◽  
Parnian Ahmadi Moghaddam ◽  
Chi Young Ok ◽  
Otto Walter ◽  
Keith Tomaszewicz ◽  
...  

2020 ◽  
Vol 65 (8) ◽  
pp. 2294-2301 ◽  
Author(s):  
Agnieszka Paziewska ◽  
Marcin Polkowski ◽  
Krzysztof Goryca ◽  
Jakub Karczmarski ◽  
Anna Wiechowska-Kozlowska ◽  
...  

Pancreas ◽  
2010 ◽  
Vol 39 (7) ◽  
pp. 1070-1076 ◽  
Author(s):  
Marie-Elisabeth Forgue-Lafitte ◽  
Ritu Arambam ◽  
Jacques Bara
Keyword(s):  

Pancreas ◽  
2009 ◽  
Vol 38 (2) ◽  
pp. e33-e42 ◽  
Author(s):  
Eileen Ke ◽  
Bhavinkumar B. Patel ◽  
Tiffany Liu ◽  
Xin-Ming Li ◽  
Oleh Haluszka ◽  
...  

1998 ◽  
Vol 24 (3) ◽  
pp. 181-186
Author(s):  
Jane M. Yang ◽  
Jeannie Lee ◽  
James F. Southern ◽  
Andrew L. Warshaw ◽  
Ela Dhanak ◽  
...  

Cancers ◽  
2020 ◽  
Vol 12 (9) ◽  
pp. 2383
Author(s):  
Misol Do ◽  
Hongbeom Kim ◽  
Dongyoon Shin ◽  
Joonho Park ◽  
Haeryoung Kim ◽  
...  

The incidence of patients with pancreatic cystic lesions, particularly intraductal papillary mucinous neoplasm (IPMN), is increasing. Current guidelines, which primarily consider radiological features and laboratory data, have had limited success in predicting malignant IPMN. The lack of a definitive diagnostic method has led to low-risk IPMN patients undergoing unnecessary surgeries. To address this issue, we discovered IPMN marker candidates by analyzing pancreatic cystic fluid by mass spectrometry. A total of 30 cyst fluid samples, comprising IPMN dysplasia and other cystic lesions, were evaluated. Mucus was removed by brief sonication, and the resulting supernatant was subjected to filter-aided sample preparation and high-pH peptide fractionation. Subsequently, the samples were analyzed by LC-MS/MS. Using several bioinformatics tools, such as gene ontology and ingenuity pathway analysis, we detailed IPMNs at the molecular level. Among the 5834 proteins identified in our dataset, 364 proteins were differentially expressed between IPMN dysplasia. The 19 final candidates consistently increased or decreased with greater IPMN malignancy. CD55 was validated in an independent cohort by ELISA, Western blot, and IHC, and the results were consistent with the MS data. In summary, we have determined the characteristics of pancreatic cyst fluid proteins and discovered potential biomarkers for IPMN dysplasia.


2012 ◽  
Vol 142 (5) ◽  
pp. S-623
Author(s):  
Eric Ellsworth ◽  
Jamie Bleicher ◽  
Brittany M. Bullion ◽  
Nicole L. Klein ◽  
W. Christine Spence ◽  
...  

2012 ◽  
Vol 107 ◽  
pp. S597
Author(s):  
Damien Mallat ◽  
Eric Ellsworth ◽  
Brendan Corcoran ◽  
Ann-Marie Terry ◽  
Syd Finkelstein

2021 ◽  
Vol 11 (8) ◽  
Author(s):  
Sheng Pan ◽  
Randall E. Brand ◽  
Lisa A. Lai ◽  
David W. Dawson ◽  
Timothy R. Donahue ◽  
...  
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document